| Application no. and date | 12183276.0 (espacenet) (Federated) (European Patent Register), 20120906 | | Patent/reg. no. and date | DK/EP 2644189, 20140514 | | Publication date | 20131002 | | Priority no. and date | US 201213431313, 20120327 | | EP pub. no. and date |
EP 2644189 20131002 | | Effective date | | | Applicant/owner | Innopharma, Inc., 10 Knightsbridge Road
Piscataway, New Jersey 08854, US | | Applicant ref. no. | P54499DK01 | | Inventor | Soppimath, Kumaresh, 8101 Timberline CT
Monmouth, NJ New Jersey 08852, US,
Pejaver, Satish, 49 Huntley Way
Bridgewater, NJ New Jersey 08807, US,
Patel, Kanaiyalal R., 252 Burroughs Terrace
Union, NJ New Jersey 07083, US,
Dasaradhi, Lakkaraju, 14, Normandy Drive
Princeton Junction, NJ New Jersey 08550, US,
Sodum, Rama, 4424 Sayre Drive
Princeton, NJ New Jersey 08540, US,
Desu, Hari, 5105, Fox Run Drive
Plainsboro, NJ New Jersey 08536, US,
Puri, Navneet, 33 Francis Drive
Bridgewater, NJ New Jersey 08807, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 47/10 (2006.01) , A61K 9/00 (2006.01) | | Title | Stabile bortezomib-formuleringer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
